论文部分内容阅读
目的观察叶下珠片联合恩替卡韦片治疗HBe Ag阳性慢性乙型肝炎(CHB)的临床疗效。方法将64例HBe Ag阳性CHB患者随机分为治疗组和对照组,每组32例,治疗组给予叶下珠片联合恩替卡韦片治疗,对照组给予恩替卡韦片治疗,治疗48周后比较二组肝功能变化,HBe Ag转阴/血清学转换率,HBV-DNA水平变化。结果治疗组肝功好转,HBe Ag转阴/血清学转换率均优于对照组。结论叶下珠片联合恩替卡韦片治疗HBe Ag阳性CHB患者,在恢复肝功能加快HBe Ag转阴/血清学转换等方面有较满意的效果。
Objective To observe the clinical efficacy of Phyllanthus tablets combined with entecavir tablets in the treatment of HBeAg-positive chronic hepatitis B (CHB). Methods Sixty-four patients with HBeAg-positive CHB were randomly divided into treatment group and control group, with 32 cases in each group. The treatment group was given YeXiaZhu tablets combined with entecavir tablets, while the control group was treated with entecavir tablets. After 48 weeks of treatment, Functional changes, HBeAg negative / seroconversion rate, HBV-DNA levels. Results The improvement of liver function and HBeAg negative / seroconversion rate in the treatment group were better than those in the control group. Conclusion The combination of Phyllanthus tablets and entecavir tablets in HBeAg-positive patients with CHB has a satisfactory effect in restoring liver function and accelerating HBeAg negative / seroconversion.